Atlas Trials

Relapsing Multiple Sclerorsis

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsing Multiple Sclerorsis

RecordFirmDate
Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS) (NCT02688985)Genentech, Inc.2016-04-29

Track Relapsing Multiple Sclerorsis automatically

Every clearance here is in the API, with alerts when new ones post.